Uric acid and left ventricular mass in prediction of cardiovascular risk-New insight from the URRAH study
- PMID: 37179137
- DOI: 10.1016/j.ejim.2023.05.016
Uric acid and left ventricular mass in prediction of cardiovascular risk-New insight from the URRAH study
Conflict of interest statement
Declaration of Competing Interest SEK reports lecture honoraria from Getz, Merck, Vector-Intas and Zydus. AH reports lecture honoraria from AstraZeneca. The third author reports no disclosure.
Comment on
-
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.Lancet. 2022 Oct 8;400(10359):1195-1205. doi: 10.1016/S0140-6736(22)01657-9. Lancet. 2022. PMID: 36216006 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical